• May 28, 2020 - We are pleased to announce that GHIAA will be conducting stakeholder consultations for the MAPGuide in June with a view to a public launch later in the summer.
  • November 18, 2019 - GHIAA is excited to announce that it is receiving support from the Wellcome Trust to further develop its online Master Alliance Provisions Guide (MAPGuide), accelerating the introduction of life-saving global health technologies by streamlining the formation of research and development alliances.
  • Nov 18, 2018 - We are excited to announce that GHIAA collaborator and student member Kushal Kadakia has been named a Rhodes Scholar (read article).
  • Oct 17, 2018 – We are pleased to share that our executive director Julie Barnes-Weise spoke at the Harvard Law school (blog post)
  • Oct 3, 2018 – We are excited to announce that our executive director Julie Barnes-Weise has been named a collaborator to the Global Access in Action (GAiA) program at Harvard (view link).
  • Sep 27, 2018 – Johnson & Johnson Announces New Collaboration to Advance Novel Vaccine for MERS (view press release).
  • May 25, 2018 – GHIAA has completed a project for the Male Contraceptive Initiative (MCI) foundation on their global funding agreements.  
  • Mar 10, 2018 – GHIAA is please to announce that Catherine Hennings (PATH) and Katherine Anastasi (Wellcome Trust) will be joining the board. We are grateful to Pamela Cox, our departing board member, for her contribution and support. 
  • Mar 7, 2018 – CEPI Partners with Themis Bioscience (read article).
  • Jan 19, 2018 – CEPI is moving ahead (read article).
  • Oct 13, 2017 –  GHIAA is pleased to announce that its Executive Director, Julia Barnes-Weise, is working with the Coalition for Epidemic Preparedness and Innovation (CEPI) on its partnering efforts and strategies. As epidemics disproportionately affect low-income countries, CEPI will ensure that the vaccines it helps to develop are affordable, so that price is never a barrier to access, and they are available to populations with the most need. CEPI will thus ensure that vaccines play the fullest possible part in containing infections with epidemic potential, to prevent them becoming public health emergencies, and build a safer world (read more about CEPI).
  • Sep 29, 2017 – GHIAA is pleased to announce that it is now a US 501 (c) (3) non-profit company and able to receive tax-deductible donations directly.
  • Sep 10, 2017 – GHIAA is pleased to announce that we are consulting with FHI 360 on contraceptive technology development partnerships (read article).
  • Jun 8, 2017 – Market-entry rewards seen as good option for getting new antibiotics (view CIDRAP article)
  • May 22, 2017 – Access to Medicines: Policy and Practice Symposium
  • March 10, 2017 – GHIAA is now a registered non-profit corporation in the state of North Carolina.

Global Health Innovation Alliance Accelerator is a 501(c)(3) non-profit recognized by the IRS.

Special thanks to the Duke Law School Community Enterprise Clinic

© 2020 Global Health Innovation Alliance Accelerator. All Rights Reserved. 

  • LinkedIn Social Icon
  • Twitter Social Icon